Myrtenol improves brain damage and promotes angiogenesis in rats with cerebral infarction by activating the ERK1/2 signalling pathway
CONCLUSIONS: Myrtenol reduced brain damage and angiogenesis through activating the ERK1/2 signalling pathway, which may provide a novel alternative strategy for preventing cerebral I/R injury. Further in vitro work detailing its mechanism-of-action for improving ischaemic cerebral infarction is needed.PMID:34010584 | DOI:10.1080/13880209.2021.1917626
Source: Pharmaceutical Biology - Category: Drugs & Pharmacology Authors: Shengming Huang Zhanguo Tan Jirui Cai Zhiping Wang Yuejun Tian Source Type: research
More News: Antidoxidants | Biology | Brain | Disability | Drugs & Pharmacology | Neurology | Study | Toxicology